The Code is periodically reviewed to ensure it remains relevant to members, the wider industry and external stakeholders, whilst continuing to align with international self-regulation and domestic policies, legislation, standards and community expectations.
The Code of Conduct Edition 19 was reviewed in 2024.
The review of Code Edition 19 took place in 2024. Members formally adopted Edition 20, by special resolution, at the Medicines Australia Annual General Meeting in October 2024. Edition 20 came into effect on 30 March 2025.
This Code Review was a consultative process involving Medicines Australia’s decision-making bodies, the Code Compliance Network, the patient community, members, and external stakeholders including the TGA. A broad consultation period ran throughout April 2024. This Consultation Paper explains the objectives, review timeframe and methodology of the review.
Opportunities to understand Edition 20.
Medicines Australia hosted a series of educational opportunities to help companies with their understanding of Edition 20. Recordings of webinars highlighting the changes and introducing Edition 20 are available on the Code Resource Toolkit. This table highlights broad changes that have occurred in the transition from Edition 19 to Edition 20.
The Medicines Australian Continuing Education Program 1 has been updated to reflect Edition 20 of the Code of Conduct. Also on offer is the Bridging Course, a shorter course to ‘bridge’ knowledge from Edition 19 to Edition 20. More information about these courses is on our website.
Previous Editions of the Code.
The previous edition of the Code, Edition 19 v2 is viewable here. This edition has been superseded by Edition 20. The Guidance and resources available in the Code Resource Toolkit have been updated to ensure relevance to Edition 20.
To access any other archived Codes of Conduct, please contact the Code Help Desk.
Medicines Australia is no longer publishing the Code of Conduct in hard copy.
Please get in touch with the MA Ethics & Compliance Team if you have any questions via email or (02) 6147 6500.